Asymchem Laboratories (06821) granted 2.711 million restricted A-shares.

date
22:44 25/08/2026
avatar
GMT Eight
Kailaiying (06821) announced that Kailaiying Pharmaceutical Group (Tianjin) Co., Ltd. (hereinafter referred to as the Company) will hold the 14th meeting of the 5th Board of Directors on August 25, 2026, to review and approve the proposal regarding the initial grant of A-share restricted stock to incentive objects. The Companys Board of Directors believes that the initial granting conditions stipulated in the 2026 Restricted Stock Incentive Plan (Draft) (hereinafter referred to as this Plan or Incentive Plan) have been met, and agrees to set August 25, 2026, as the initial grant date, granting 2.711 million shares of restricted stock to 622 incentive objects.
Asymchem Laboratories (06821) announced that Asymchem Laboratories Pharmaceutical Group (Tianjin) Co., Ltd. (hereinafter referred to as the "Company") held the 14th meeting of the 5th Board of Directors on August 25, 2026, to review and approve the proposal on the initial granting of restricted A-shares to incentive objects. The Board of Directors believes that the initial granting conditions stipulated in the "2026 Restricted Stock Incentive Plan (Draft)" (hereinafter referred to as "this Plan" or "Incentive Plan") have been fulfilled, and agrees to set August 25, 2026, as the initial grant date, awarding 2.711 million shares of restricted stock to 622 incentive recipients.